PharmacyCodes



Cefaloglycine [INN-French] en es it fr

Cefaloglycine [INN-French] Brand names, Cefaloglycine [INN-French] Analogs

Cefaloglycine [INN-French] Brand Names Mixture

  • No information avaliable

Cefaloglycine [INN-French] Chemical_Formula

C18H19N3O6S

Cefaloglycine [INN-French] RX_link

No information avaliable

Cefaloglycine [INN-French] fda sheet

Cefaloglycine [INN-French] msds (material safety sheet)

Cefaloglycine [INN-French] Synthesis Reference

No information avaliable

Cefaloglycine [INN-French] Molecular Weight

405.426 g/mol

Cefaloglycine [INN-French] Melting Point

237 oC

Cefaloglycine [INN-French] H2O Solubility

154 mg/L

Cefaloglycine [INN-French] State

Solid

Cefaloglycine [INN-French] LogP

-0.256

Cefaloglycine [INN-French] Dosage Forms

No information avaliable

Cefaloglycine [INN-French] Indication

For treatment of severe infections caused by susceptible bacteria.

Cefaloglycine [INN-French] Pharmacology

Cephaloglycin is an antibiotic related to cephalosporin but no longer in common use. It is an orally absorbed derivative of cephalosporin C.

Cefaloglycine [INN-French] Absorption

Well absorbed following oral administration.

Cefaloglycine [INN-French] side effects and Toxicity

Adverse effects following overdosage include nausea, vomiting, epigastric distress, diarrhea, and convulsions.

Cefaloglycine [INN-French] Patient Information

No information avaliable

Cefaloglycine [INN-French] Organisms Affected

Enteric bacteria and other eubacteria